Skip to content

Study of Prevention of Postoperative Delirum to Reduce Incidence of Postoperative Cognitive Dysfunction

The Influence of Non-medication-based Prophylaxis of Postoperative Delirium on Postoperative Delirium and Cognitive Deficit

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03060174
Acronym
DelPOCD
Enrollment
638
Registered
2017-02-23
Start date
2014-05-31
Completion date
2021-05-31
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction, Postoperative Delirium

Brief summary

Postoperative cognitive dysfunction describes a condition where cognitive functions such as attention, perception, concentration, learning, abstract thinking and problem solving are impaired postoperatively. These changes can be resolved after weeks and months, but in some cases may be permanent. The aetiology is multifactorial. One risk factor for developing POCD is the occurrence of postoperative delirium. A total of 638 consecutive patients will be enrolled in the study. Patients will be followed up at 7 days, 3 months and 1 year postoperatively. The cognitive function will be tested and compared to tests done before surgery. Postoperatively (from the day of operation until the 7th day and except of day 6) the grade of sedation; agitation; signs of delirium; pain; cardiac; respiratory; renal and infectious complications will be recorded. As possible influencing factors, the investigators will document diagnosed depression; comorbidities; intraoperative blood loss; length of hospital stay; 1-year-mortality; number of operations/anaesthetics undergone after the initial operation. Parameters that could trigger either depressive symptoms, neurocognitive dysfunction, anxiety, fatigue or lack of concentration will be recorded. These include: anaemia, hypercalcaemia, thyroidal gland hormones, electrolytes, creatinine, urea, glomerular filtration rate, cortisone therapy and adrenal cortical insufficiency.

Detailed description

The methods include a neuropsychological test battery: TAP 2.3 (attention), Trail Making Test (TMT )A+B (attention), Digit span (memory), (Visual Learning and Memory Test (VLMT) (memory), Regensburgerwortfluessigkeitstest/fluency (RWT) subtests (executive function), Mehrfach-Wortschatz-Intelligenztest/vocabulary (MWT-B) (premorbid IQ). Other measures are Hospital Anxiety and Depression Scale (HADS-D) (depressive symptoms and anxiety), Mini Mental State Examination (MMSE) 2 (dementia), Confusion Assessment Method (CAM-ICU) (delirium), Richmond Agitation and Sedation Scale (RASS) (sedation and agitation), Numeric Rating Scale (NRS) (pain) and Short Form Health Survey (SF-12) (health related quality of life).

Interventions

OTHERmonitoring and non-medical prophylaxis of delirium

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 60 years * Cardiac surgery (on-pump/off-pump, standard/minimal invasive) * Written informed patient's consent

Exclusion criteria

* Non-German speaking or not their first language * Illiteracy * Mental disability * Non-corrigible vision impairment * Non-corrigible hearing impairment * Illegal substance abuse (current or past history) * Alcohol abuse (current or past history) * Chronic benzodiazepine use * Psychosis (current or past history) * Parkinson Disease * Dementia * Multiple sclerosis * Epilepsy (current or past history) * Cerebral tumor (current or past history) * Apoplexy or intracranial bleeding (current or past history) * Severe traumatic brain injury (current or past history) * Severe liver disease (Child Pugh B, C, liver insufficiency) * Severe kidney disease with dialysis * Mini Mental Status Examination \< 24 points

Design outcomes

Primary

MeasureTime frameDescription
postoperative cognitive deficit (POCD)change from baseline in cognitive function at day 7, 3 months and 1 year after operationmeasured by neuropsychological test battery, analysis

Secondary

MeasureTime frameDescription
length of hospital stayfrom day of admission until day of discharge, up to 24 weeks
health related quality of life3 months, 1 year after operationShort Form Health Survey (SF-12)
number of patients with respiratory complicationsday of operation until 7th postoperative daydaily documentation of pulmonary complications (pneumonia, pulmonary oedema, others),
number of patients with renal complicationsday of operation until 7th postoperative daydaily documentation of renal complications (creatinine, haemo(dia)filtration or haemodialysis)
number of patients with complications in the immunosystemday of operation until 7th postoperative daydaily documentation of parameters mirroring the immune answer (C-reactive protein, leukocytes, procalcitonin)
incidence and severity of postoperative deliriumfrom the day of operation until the 7th postoperative daymeasured 3 times per day via CAM-ICU
number of patients with cardiac complicationsday of operation until 7th postoperative daydaily documentation of cardiac complications (central venous oxygen saturation, myocardial infarction, acute heart failure, others)
mortality1 year

Other

MeasureTime frameDescription
haemoglobin (Anaemia) on a scoreintraoperativeScore Hb \< 6 g/dl, 6-7.99 g/dl, 8-9.99 g/dl, \> 9.99 g/dl
blood lossintraoperativeestimated blood loss in milliliter
anxiety and depressive symptoms on HADS-D7 days, 3 months, 1 year after operationThe Hospital Anxiety and Depression Scale (HADS-D) is used to measure depressive symptoms. The 7 items are answered on a 4-point scale from 0 to 3 with a scale score varying between 0 and 21 (0-7 = normal, 8-10 = borderline, 11-14 = severe depressive symptoms, \>15 very severe depressive symptoms).
postoperative pain scores on the numeric rating scale (NRS)day of operation until 7th postoperative day, 3 months, 1 year after operationscale

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026